The Food and Drug Administration granted Fast Track designation to INSYS Therapeutics Inc. (Nasdaq: INSY) for its cannabidiol oral solution to treat Prader-Willi syndrome sending the stock price up $1.08 to close at $8.20.
Fast Track designation granted to INSYS Therapeutics
December 26, 2017 at 17:26 PM EST
